Skip to main content
AAN.com
×
Site maintenance Tuesday, June 24, 2025. Please note that new registrations and purchases will be unavailable on this date.
Articles
March 29, 2010

Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function

March 30, 2010 issue
74 (13) 1022-1029

Abstract

Objective: C-reactive protein is a marker of inflammation and vascular disease. It also seems to be associated with an increased risk of dementia. To better understand potential underlying mechanisms, we assessed microstructural brain integrity and cognitive performance relative to serum levels of high-sensitivity C-reactive protein (hs-CRP).
Methods: We cross-sectionally examined 447 community-dwelling and stroke-free individuals from the Systematic Evaluation and Alteration of Risk Factors for Cognitive Health (SEARCH) Health Study (mean age 63 years, 248 female). High-field MRI was performed in 321 of these subjects. Imaging measures included fluid-attenuated inversion recovery sequences for assessment of white matter hyperintensities, automated quantification of brain parenchyma volumes, and diffusion tensor imaging for calculation of global and regional white matter integrity, quantified by fractional anisotropy (FA). Psychometric analyses covered verbal memory, word fluency, and executive functions.
Results: Higher levels of hs-CRP were associated with worse performance in executive function after adjustment for age, gender, education, and cardiovascular risk factors in multiple regression analysis (β = −0.095, p = 0.02). Moreover, higher hs-CRP was related to reduced global fractional anisotropy (β = −0.237, p < 0.001), as well as regional FA scores of the frontal lobes (β = −0.246, p < 0.001), the corona radiata (β = −0.222, p < 0.001), and the corpus callosum (β = −0.141, p = 0.016), in particular the genu (β = −0.174, p = 0.004). We did not observe a significant association of hs-CRP with measures of white matter hyperintensities or brain atrophy.
Conclusion: These data suggest that low-grade inflammation as assessed by high-sensitivity C-reactive protein is associated with cerebral microstructural disintegration that predominantly affects frontal pathways and corresponding executive function.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (appendix_e-1.doc)
File (figure_e-1_legend.doc)
File (figure_e1.tif)
File (table_e-1.doc)
File (table_e-2.doc)

REFERENCES

1.
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557–1565.
2.
Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32:2575–2579.
3.
Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168–174.
4.
Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034–2041.
5.
Hoshi T, Kitagawa K, Yamagami H, et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005;36:768–772.
6.
van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005;112:900–905.
7.
Fornage M, Chiang YA, O'Meara ES, et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: The Cardiovascular Health Study. Stroke 2008;39:1952–1959.
8.
Gunstad J, Bausserman L, Paul RH, et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 2006;13:540–546.
9.
Schmidt R, Schmidt H, Pichler M, et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke 2006;37:2910–2916.
10.
Deppe M, Duning T, Mohammadi S, et al. Diffusion-tensor imaging at 3 T: detection of white matter alterations in neurological patients on the basis of normal values. Invest Radiol 2007;42:338–345.
11.
Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 2008;34:51–61.
12.
Schiavone F, Charlton RA, Barrick TR, Morris RG, Markus HS. Imaging age-related cognitive decline: a comparison of diffusion tensor and magnetization transfer MRI. J Magn Reson Imaging 2009;29:23–30.
13.
Knecht S, Wersching H, Lohmann H, et al. High-normal blood pressure is associated with poor cognitive performance. Hypertension 2008;51:663–668.
14.
Lezak MD. Neuropsychological Assessment, 4th ed. New York: Oxford University Press; 2004.
15.
Scheltens P, Erkinjunti T, Leys D, et al. White matter changes on CT and MRI: an overview of visual rating scales: European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80–89.
16.
Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–489.
17.
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499–511.
18.
Hoth KF, Haley AP, Gunstad J, et al. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J Am Geriatr Soc 2008;56:1898–1903.
19.
Wright CB, Sacco RL, Rundek TR, et al. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006;15:34–38.
20.
Carlson MC, Xue QL, Zhou J, Fried LP. Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci 2009;64:110–117.
21.
Jefferson AL, Paul RH, Ozonoff A, Cohen RA. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). Arch Clin Neuropsychol 2006;21:311–320.
22.
Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008;131:3286–3298.
23.
Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515–525.
24.
Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999–2005.
25.
Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897–1908.
26.
Reitz C, Berger K, de Maat MP, et al. CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke 2007;38:2356–2359.
27.
Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta 1985;153:9–13.
28.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131–2135.
29.
Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424–432.
30.
Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165–2168.
31.
Meier-Ruge W, Ulrich J, Bruhlmann M, Meier E. Age-related white matter atrophy in the human brain. Ann NY Acad Sci 1992;673:260–269.
32.
Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005;66:265–275.
33.
Dik MG, Jonker C, Hack CE, et al. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005;64:1371–1377.
34.
Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F. High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006;17:183–189.
35.
Ockene IS, Matthews CE, Rifai N, et al. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001;47:444–450.
36.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–979.
37.
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195–2207.
38.
Lakka TA, Lakka HM, Rankinen T, et al. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 2005;26:2018–2025.
39.
Witte AV, Fobker M, Gellner R, Knecht S, Floel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci USA 2009;106:1255–1260.

Information & Authors

Information

Published In

Neurology®
Volume 74Number 13March 30, 2010
Pages: 1022-1029
PubMed: 20350977

Publication History

Published online: March 29, 2010
Published in issue: March 30, 2010

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

H. Wersching, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
T. Duning, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
H. Lohmann, PhD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
S. Mohammadi, PhD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
C. Stehling, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
M. Fobker, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
M. Conty
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
J. Minnerup, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
E.B. Ringelstein, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
K. Berger, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
M. Deppe, PhD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.
S. Knecht, MD
From the Department of Neurology (H.W., T.D., H.L., S.M., M.C., J.M., E.B.R., M.D., S.K.), Institute of Epidemiology and Social Medicine (H.W., K.B.), Institute of Clinical Radiology (C.S.), and Institute of Clinical Chemistry and Laboratory Medicine (M.F.), University of Münster, Münster, Germany.

Notes

Address correspondence and reprint requests to Dr. Heike Wersching, Institute of Epidemiology and Social Medicine, University of Münster, Domagkstraße 3, 48149 Münster, Germany [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Fluid biomarkers of vascular cognitive Impairment: From vascular pathophysiology to potential clinical applications, Neuroscience, 579, (267-283), (2025).https://doi.org/10.1016/j.neuroscience.2025.06.018
    Crossref
  2. The association between C-reactive protein and neuroimaging findings in mood disorders: A review of structural and diffusion MRI studies, Journal of Affective Disorders, 381, (643-658), (2025).https://doi.org/10.1016/j.jad.2025.03.175
    Crossref
  3. Atrial fibrillation-related ischemic stroke and cognitive impairment: Research progress on the characteristics and pathogenesis, Brain Research Bulletin, 227, (111392), (2025).https://doi.org/10.1016/j.brainresbull.2025.111392
    Crossref
  4. Research Progress in the Pathogenesis of Cognitive Dysfunction in White Matter Hyperintensities: A Narrative Review, Journal of Integrative Neuroscience, 24, 2, (2025).https://doi.org/10.31083/JIN24840
    Crossref
  5. Associations of high-sensitivity C-reactive protein with neuropsychological outcomes and cerebral white matter hyperintensities in older adults at risk of dementia, Brain, Behavior, & Immunity - Health, 43, (100924), (2025).https://doi.org/10.1016/j.bbih.2024.100924
    Crossref
  6. Intracranial atherosclerotic disease and neurodegeneration: a narrative review and plausible mechanisms, Journal of Stroke and Cerebrovascular Diseases, 33, 12, (108015), (2024).https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108015
    Crossref
  7. Brain morphometry and chronic inflammation in Bangladeshi children growing up in extreme poverty, Imaging Neuroscience, 2, (1-16), (2024).https://doi.org/10.1162/imag_a_00319
    Crossref
  8. Association of direct oral anticoagulants and warfarin with incidence of dementia in atrial fibrillation patients: A systematic review and meta-analysis, IJC Heart & Vasculature, 54, (101401), (2024).https://doi.org/10.1016/j.ijcha.2024.101401
    Crossref
  9. Could the Early Detection of Atrial Fibrillation Reduce the Risk of Developing Dementia?, Biomedicines, 12, 8, (1931), (2024).https://doi.org/10.3390/biomedicines12081931
    Crossref
  10. Greater methylation of the IL-6 promoter region is associated with decreased integrity of the corpus callosum in schizophrenia, Journal of Psychiatric Research, 175, (108-117), (2024).https://doi.org/10.1016/j.jpsychires.2024.05.013
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share